Serina Therapeutics, Inc.·4

Sep 20, 6:59 PM ET

Bailey Gregory 4

4 · Serina Therapeutics, Inc. · Filed Sep 20, 2024

Insider Transaction Report

Form 4
Period: 2024-09-18
Transactions
  • Purchase

    Common Stock

    2024-09-18$6.23/sh+2,709$16,87350,561 total
  • Purchase

    Common Stock

    2024-09-19$6.11/sh+11,679$71,38462,240 total
Footnotes (2)
  • [F1]The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.18 per share to a high of $6.25 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
  • [F2]The price reflects the weighted average purchase price of multiple transactions ranging from a low of $5.96 per share to a high of $6.25 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.

Documents

1 file
  • 4
    ownership.xmlPrimary